CAS: 1233322-09-2
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | BI-69A11 REF: TM-T25150CAS: 1233322-09-2 | 96.97% | 45,00 €~361,00 € | Ter 17 Dez 24 |
 | (E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one REF: 3D-IZB32209CAS: 1233322-09-2 | Min. 95% | A consultar | Ter 21 Jan 25 |
BI-69A11
CAS:1233322-09-2
BI-69A11 is a dual AKT/NFkB inhibitor, increasing colon cancer cell sensitivity to mda-7/IL-24.
Fórmula:
C25H16ClN3O2
Pureza:
96.97%
Cor e Forma:
Solid
Peso molecular:
425.87
Ref: TM-T25150
| 1mg | 45,00 € | ||
| 2mg | 58,00 € | ||
| 5mg | 83,00 € | ||
| 10mg | 97,00 € | ||
| 25mg | 182,00 € | ||
| 50mg | 261,00 € | ||
| 100mg | 361,00 € | ||
| 1mL*10mM (DMSO) | 94,00 € |
Entrega estimada em Estados Unidos, Terça-feira 17 de Dezembro de 2024
![(E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one](https://static.cymitquimica.com/products/3D/thumb/IZB32209.jpg)
(E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one
CAS:1233322-09-2
(E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one is a novel anticancer drug that is currently undergoing clinical trials. It has been …
Fórmula:
C25H16ClN3O2
Pureza:
Min. 95%
Peso molecular:
425.9 g/mol
Ref: 3D-IZB32209
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada em Estados Unidos, Terça-feira 21 de Janeiro de 2025
